Pillstats
Rx only · Tablet, Film Coated · Oral

Ketorolac Tromethamine

Ketorolac Tromethamine

26 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US50 NDCs
26 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)35827
US makers28 labelers
Packages155
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 10 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.051$0.101$0.152$0.203Dec 2025Apr 2026Jul 2026
$0.168
Latest avg · Jul 22, 2026
+14%
Since Dec 17, 2025
26
Active US suppliers
41%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

65K130K194K259K2025 Q12025 Q22025 Q32025 Q42026 Q1
204K
Rx · 2026 Q1
3.4M
Units dispensed
-2%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it26 active · 2 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Bryant Ranch Prepackrepackager50SUPPLYING
A-S Medication Solutionsunknown12SUPPLYING
Asclemed USA, Inc.unknown10SUPPLYING
Proficient Rx LPunknown9SUPPLYING
ADVANCED RX PHARMACY OF TENNESSEE, LLCunknown8SUPPLYING
Sportpharm LLCunknown8SUPPLYING
NuCare Pharmaceuticals, Inc.unknown7SUPPLYING
PD-Rx Pharmaceuticals, Inc.unknown7SUPPLYING
REMEDYREPACK INC.repackager6SUPPLYING
Redpharm Drugunknown6SUPPLYING
Advanced Rx of Tennessee, LLCunknown5SUPPLYING
Northwind Health Company, LLCunknown4SUPPLYING
Preferred Pharmaceuticals Inc.unknown4SUPPLYING
Direct_Rxunknown4SUPPLYING
Injecta Medcial LLCunknown2SUPPLYING

+ 13 more labelers

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Apr 20, 2026
    RESOLVEDShortage resolved: Ketorolac Tromethamine Tablet (Mylan Pharmaceuticals Inc., a Viatris Company)

    Ketorolac Tromethamine Tablet — reported in shortage by Mylan Pharmaceuticals Inc., a Viatris Company. Therapeutic category: Analgesia/Addiction.

  • Apr 20, 2026
    SHORTAGEDrug shortage: Ketorolac Tromethamine Tablet (Mylan Pharmaceuticals Inc., a Viatris Company)

    Ketorolac Tromethamine Tablet — reported in shortage by Mylan Pharmaceuticals Inc., a Viatris Company. Therapeutic category: Analgesia/Addiction.